Christopher Kenney
Overview
Explore the profile of Christopher Kenney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
782
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
French J, Porter R, Perucca E, Brodie M, Rogawski M, Harden C, et al.
Epilepsia Open
. 2025 Mar;
PMID: 40053315
Objective: To report interim data from an ongoing, open-label extension (OLE) of a Phase 2b study (X-TOLE) of azetukalner in adults with focal onset seizures (FOS) receiving 1-3 antiseizure medications....
2.
Niemann B, Kenney C, Marsh J, Schmidt C, Boone B
J Robot Surg
. 2024 Jun;
18(1):253.
PMID: 38878073
Robotic surgery is increasingly utilized in hepatopancreatobiliary (HPB) surgery, but the learning curve is a substantial obstacle hindering implementation. Comprehensive robotic training can help to surmount this obstacle; however, despite...
3.
Niemann B, Kenney C, Marsh J, Schmidt C, Boone B
Res Sq
. 2024 May;
PMID: 38746355
Background: Robotic surgery is increasingly utilized in hepatopancreatobiliary (HPB) surgery, but the learning curve is a substantial obstacle hindering implementation. Comprehensive robotic training can help to surmount this obstacle; however,...
4.
French J, Porter R, Perucca E, Brodie M, Rogawski M, Pimstone S, et al.
JAMA Neurol
. 2023 Oct;
80(11):1145-1154.
PMID: 37812429
Importance: Many patients with focal epilepsy experience seizures despite treatment with currently available antiseizure medications (ASMs) and may benefit from novel therapeutics. Objective: To evaluate the efficacy and safety of...
5.
Kerr W, Auvin S, Van der Geyten S, Kenney C, Novak G, Fountain N, et al.
Epilepsia
. 2023 Apr;
64(7):1699-1708.
PMID: 37073881
Well-designed placebo-controlled clinical trials are critical to the development of novel treatments for epilepsy, but their design has not changed for decades. Patients, clinicians, regulators, and innovators all have concerns...
6.
Zhou H, Nguyen H, Enriquez A, Morsy L, Curtis M, Piser T, et al.
Neurol Sci
. 2021 Oct;
43(4):2589-2599.
PMID: 34664180
Objective: To explore the use of wearable sensors for objective measurement of motor impairment in spinocerebellar ataxia (SCA) patients during clinical assessments of gait and balance. Methods: In total, 14...
7.
van Driel T, Nelson S, Armenta R, Blaj G, Boo S, Boutet S, et al.
J Synchrotron Radiat
. 2020 May;
27(Pt 3):608-615.
PMID: 32381760
The ePix10ka2M (ePix10k) is a new large area detector specifically developed for X-ray free-electron laser (XFEL) applications. The hybrid pixel detector was developed at SLAC to provide a hard X-ray...
8.
Olanow C, Kenney C, Bandak S, Kieburtz K
Mov Disord
. 2018 Nov;
33(11):1685-1687.
PMID: 30383315
No abstract available.
9.
Schapira A, Fox S, Hauser R, Jankovic J, Jost W, Kenney C, et al.
JAMA Neurol
. 2016 Dec;
74(2):216-224.
PMID: 27942720
Importance: Although levodopa remains the most effective oral pharmacotherapy for Parkinson disease (PD), its use is often limited by wearing off effect and dyskinesias. Management of such complications continues to...
10.
Mancel V, Mathy F, Boulanger P, English S, Croft M, Kenney C, et al.
Xenobiotica
. 2016 Aug;
47(8):705-718.
PMID: 27489076
1. This phase-I study (NCT02240290) was designed to investigate the human absorption, disposition and mass balance of C-tozadenant, a novel A2a receptor antagonist in clinical development for Parkinson s disease....